877-272-6226
News and Stories About NIH-NCI
2020 Year in Review: Advocacy Accomplishments
Editor’s note: In today’s edition of our Year in Review series, we’re looking back at the wins you made possible […]
READ MORE
Breaking News: Federal Research Program for Pancreatic Cancer Increases to $15 Million
Thousands of advocates delivered a strong message to Capitol Hill: Make pancreatic cancer a national priority. And Congress responded. Congress […]
READ MORE
2019 Year in Review: Advocacy Wins
Editor’s note: Today’s installment of our 2019 Year in Review series highlights the important work of our advocates across the […]
READ MORE
U.S. Senator Holds Pancreatic Cancer Congressional Field Hearing
In response to the disease’s impact on his constituents in Alabama, Sen. Doug Jones (D-AL) presided over a hearing entitled, […]
READ MORE
Medical Research Community Rallies for NIH Funding
Today, the Pancreatic Cancer Action Network (PanCAN) joins the American Association for Cancer Research (AACR) and the medical research community […]
READ MORE
Pancreatic Cancer Action Week: Make This Moment Matter
Today, June 19, is the start of Pancreatic Cancer Action Week, and it’s time to raise your voice for pancreatic […]
READ MORE
‘Bench to Bedside’ Project Shows Promise in Pancreatic Cancer Patients
A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE
NCI Increases Pancreatic Cancer Research Funding
Nearly $178 million was invested in pancreatic cancer research by the National Cancer Institute (NCI) in 2017 – a 17 […]
READ MORE
Research Shows Racial Inequalities in Cancer Care
Editor’s Note: In honor of National Minority Health Month, we would like to shed some light on the issues of […]
READ MORE
Advocate for Pancreatic Cancer Patients in 2019
As the nation marked the beginning of 2019, the 116th Congress kicked off with nearly 100 newly elected members taking […]
READ MORE
Partial Government Shutdown Impact on Pancreatic Cancer Patients
A partial government shutdown has been in place for the past three weeks, and there is still no end in […]
READ MORE
2018 Year in Review: Advocates Moved the Needle Forward
Editor’s note: Our advocates shine in today’s installment of our 2018 Year in Review series. See how they significantly increased […]
READ MORE
Partial Government Shutdown Would Not Affect Health Agencies
A partial government shutdown is possible before the end of the calendar year due to a standoff between President Trump […]
READ MORE
Congress Approves $2 Billion Increase for Medical Research
Taking a strong stance on the importance of investing in medical research to fight cancer and other diseases, Congress approved […]
READ MORE
The Current Status of Pancreatic Cancer Legislative Priorities
The Pancreatic Cancer Action Network’s (PanCAN) legislative priorities are to increase the federal research investment into the disease – a […]
READ MORE
4 Ways to Become an Advocate for Pancreatic Cancer Research
The Pancreatic Cancer Action Network’s (PanCAN) National Pancreatic Cancer Advocacy Day in Washington, D.C., was a success, thanks to hundreds of advocates […]
READ MORE
Prestigious Scientific Panel Discusses Key Topics at Pancreatic Cancer Advocacy Day
Today at National Pancreatic Cancer Advocacy Day, a prestigious panel of scientific and clinical leaders discussed key topics surrounding the […]
READ MORE
Congress Approves Largest Research Funding Increase Since 2003
Pancreatic cancer research achieved a big win in the nation’s capital when the 2018 omnibus bill was passed last week […]
READ MORE
2017 Year in Review: Advocacy in Action
In 2017, Pancreatic Cancer Action Network (PanCAN) advocates raised their voice and moved the needle toward our goal of doubling […]
READ MORE
The NCI Funds Early Detection
The National Cancer Institute (NCI) recently funded four new teams of researchers through its Pancreatic Cancer Detection Consortium (PCDC). According […]
READ MORE
Hispanics Losing Opportunities to Access Leading-Edge Treatments for Pancreatic Cancer
A news article originally published in USA Today explored the relatively low number of Hispanics who enroll in clinical trials […]
READ MORE
PanCAN Heads For ‘The Hill’
This morning, more than 650 advocates including over 100 pancreatic cancer survivors, stormed our nation’s capital to urge Congress to […]
READ MORE
Proposed Budget Cuts Could Hurt Pancreatic Cancer Research Efforts
Today, the Trump administration released its full fiscal year (FY) 2018 budget, proposing deep cuts to the National Institutes of […]
READ MORE
A Message from our President and CEO: Your Activism and Advocacy Can Save Lives
As the House of Representatives voted to pass the American Health Care Act recently, I thought of the thousands of […]
READ MORE
“I’m Drawn to Tough Challenges!” A Conversation with Dr. Andrew Hendifar
Research funding is critical to improving pancreatic cancer patient outcomes. But unfortunately, there simply isn’t enough of it. A study […]
READ MORE
Annual Report to the Nation on the Status of Cancer Finds Rates Declining, But Not In Pancreatic Cancer
Today, the American Cancer Society, the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) released […]
READ MORE
Leadership Discusses Pancreatic Cancer Research Funding, New Report
The Pancreatic Cancer Action Network’s Scientific & Medical Affairs team acknowledged for key contributions to a study analyzing the pancreatic […]
READ MORE
Standing room-only crowd attends congressional briefing, raising awareness for our nation’s deadliest cancers
The deadliest cancers in the United States are defined by the Recalcitrant Cancer Research Act, legislation the Pancreatic Cancer Action […]
READ MORE
